Call Us08045477330
Bortezomib Injection 3.5 mg

Bortezomib Injection 3.5 mg

3200 INR/Box

Product Details:

  • Indication Multiple Myeloma, Mantle Cell Lymphoma
  • Dosage Form Lyophilized Powder for Injection
  • Salt Composition Bortezomib 3.5 mg/vial
  • Feature Preservative free, single-dose vial
  • Ingredients Bortezomib, Mannitol (Excipients)
  • Application Intravenous (IV) or Subcutaneous (SC) use after reconstitution
  • Ph Level Neutral (typically 6.57.5 after reconstitution)
  • Click to View more
X

Bortezomib Injection 3.5 mg Price And Quantity

  • 1 Box
  • 3200 INR/Box

Bortezomib Injection 3.5 mg Product Specifications

  • Preservative free, single-dose vial
  • White to off-white lyophilized powder
  • Bortezomib, Mannitol (Excipients)
  • Store at 28C (Refrigerated), protect from light
  • Odorless
  • 24 months from manufacturing date
  • Neutral (typically 6.57.5 after reconstitution)
  • Multiple Myeloma, Mantle Cell Lymphoma
  • Lyophilized Powder for Injection
  • Bortezomib 3.5 mg/vial
  • Intravenous (IV) or Subcutaneous (SC) use after reconstitution

Bortezomib Injection 3.5 mg Trade Information

  • Cash Against Delivery (CAD), Cash on Delivery (COD), Cash in Advance (CID), Cash Advance (CA)
  • 1000 Box Per Day
  • 1 Week
  • 3.5 mg/ Vial
  • All India
  • GMP

Product Description



Experience the extraordinary therapeutic benefits of Bortezomib Injection 3.5 mg, now available at a reduced price during our special clearance event! This exceptional prescription-only medication, presented as a single-use vial, contains 3.5 mg of Bortezomib lyophilized powder, ready for healthcare professional administration via intravenous or subcutaneous routes. Add to Cart for a premium solution in the treatment of Multiple Myeloma and Mantle Cell Lymphoma. Featuring a preservative-free, odorless formulation, this transcendent therapy delivers stability, efficacy, and reliability throughout its 24-month shelf life. Store refrigerated and protect from light for optimal potency.

Transcendent Therapeutic Solution: Key Advantages and Application Scope

Bortezomib Injection 3.5 mg stands out for its remarkable efficacy in treating Multiple Myeloma and Mantle Cell Lymphoma. Its preservative-free, single-use vial maintains high safety standards, while compatibility with both IV and SC administration ensures flexible application. The products machine-free simplicity streamlines workflows for healthcare professionals, reinforcing both reliability and convenience. Its neutral pH and stable, odorless formulation further distinguish this injection as an exceptional choice in oncological therapies.


Premium Supply & Packaging Expertise: Seamless, Reliable Distribution

Our supply ability ensures an uninterrupted flow of premium Bortezomib Injection 3.5 mg products across India and beyond. Shipped goods are securely packed in temperature-controlled packaging, preserving stability from dispatch to delivery. List price options accommodate various order quantities, while sample availability allows for confident evaluation before bulk purchase. Exceptional handling guarantees the medicines integrity at every distribution stage, catering to distributors, wholesalers, exporters, and suppliers alike.


FAQs of Bortezomib Injection 3.5 mg:


Q: How should Bortezomib Injection 3.5 mg be administered?

A: Bortezomib Injection 3.5 mg should only be administered by a qualified healthcare professional through intravenous (IV) or subcutaneous (SC) routes after proper reconstitution using 0.9% Sodium Chloride Injection.

Q: What are the primary indications for using Bortezomib Injection 3.5 mg?

A: This medication is primarily indicated for the treatment of Multiple Myeloma and Mantle Cell Lymphoma, offering advanced support in oncology care.

Q: When should Bortezomib Injection not be used?

A: Bortezomib Injection should not be used in patients with known hypersensitivity to Bortezomib or boron, as outlined in the contraindications section.

Q: Where should the Bortezomib Injection be stored?

A: The injection should be stored refrigerated at temperatures between 28C and protected from light to preserve its stability and efficacy.

Q: What is the process for reconstitution and stability of Bortezomib Injection?

A: Reconstitute the lyophilized powder with 0.9% Sodium Chloride Injection; the solution remains stable for up to 8 hours at room temperature and must be used within this period.

Q: How does Bortezomib Injections packaging ensure product quality during shipping?

A: All shipped goods are stored in secure, temperature-controlled packaging that maintains product integrity and meets premium pharmaceutical standards.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in 'Anti Cancer Injection' category